Omalizumab decreases respiratory viral infections in children with allergic asthma (PROSE)

Omalizumab decreases respiratory viral infections in children with allergic asthma (PROSE) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Omalizumab decreases respiratory viral infections in children with allergic asthma (PROSE) ID - 1314391 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314391/all/Omalizumab_decreases_respiratory_viral_infections_in_children_with_allergic_asthma__PROSE_ PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -